NYSE: PBH
- Last Close 59.03
- Sector Healthcare
- Industry Drug Manufacturers - Specialty & Generic
- Investment Style Small Blend
- Day Range 58.11 – 59.13
- Year Range 48.51 – 67.45
- Market Cap 2.9334 Bil
- Volume / Avg 204,203.0 / 244,689.8
- Price / Sales 2.61
- Price / Book 2.03
- Forward Div Yield —
- Trailing Div Yield 0.80%
Morningstar‘s Stock Analysis PBH
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile PBH
Prestige Consumer Healthcare is an American company that distributes branded over-the-counter healthcare and household cleaning products to mass merchandisers, drugstores, convenience stores, supermarkets, and e-commerce channels. The firm's major brands include BC/Goody's, Chloraseptic, Clear Eyes, Compound W, Debrox, Dramamine, Fess, Fleet, Gaviscon, Hydralyte, Monistat, Nix, and Summer's Eve. The company's portfolio includes branded products in women's health, gastrointestinal, analgesics, eye and ear care, dermatological products, oral care, skincare, sleep aids, and cough and cold. Its segments include North American OTC Healthcare and International OTC Healthcare.
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of PBH’s competitive advantage.
Prestige Consumer Healthcare Inc
XNYS: PBH
| Clorox Co
XNYS: CLX
| Johnson & Johnson
XNYS: JNJ
| Newell Brands Inc
XNAS: NWL
| |
Price
| 59.03 | 159.09 | 154.35 | 8.73 |
Currency
| USD | USD | USD | USD |
Change
| +$0.68 (1.17%) | +$0.75 (0.47%) | −$0.06 (0.04%) | +$0.27 (3.19%) |
Market Cap
| 2.93 Bil | 19.67 Bil | 401.11 Bil | 3.62 Bil |
Industry
| Drug Manufacturers - Specialty & Generic | Household & Personal Products | Drug Manufacturers - General | Household & Personal Products |
Sector
|
Healthcare
|
Consumer Defensive
|
Healthcare
|
Consumer Defensive
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Prestige Consumer Healthcare Inc Stock
No. PBH does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
PBH’s market cap is 2.93 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
PBH’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
PBH’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare PBH’s historical performance against its industry peers and the overall market.